1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsOpen call specifically for female-identifying visual artists aged 35 and under from listed European countries to support artistic practice and visibility.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Female-identifying visual artists ≤35, citizens or residents of Albania, Belarus, Bosnia and Herzegovina, Czech Republic, Hungary, Kosovo, Moldova, Montenegro, North Macedonia, Poland, Serbia, Slovakia or Ukraine. Confirm the full requirements in the official notice before applying.
The current listing shows €500 grants (multiple available). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Secondary Archive Open Call for Women Artists from V4, WB and EAP are due November 15, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Secondary Archive Open Call for Women Artists from V4, WB and EAP is funded by Katarzyna Kozyra Foundation (with European Cultural Foundation support). Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 CT Not Allowed) is sponsored by U.S. Department of Health and Human Services; National Institutes of Health. This NOFO supports secondary analysis of archived HIV data to advance maternal and pediatric HIV research, emphasizing data sharing and innovative methods. Modeling approaches could be used to analyze these datasets.
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed) is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This grant supports the secondary analysis of archived HIV data to advance maternal and pediatric HIV research, with an emphasis on data sharing and innovative methodologies.
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 CT Not Allowed) is sponsored by U.S. Department of Health and Human Services, National Institutes of Health. Supports secondary analysis of archived HIV data to advance maternal and pediatric HIV research, emphasizing data sharing and innovative methods, which can include virological studies.
With Forms J in FY2027, NIH will no longer accept letters of support — the boilerplate endorsements applicants have padded proposals with for decades. Notice NOT-OD-26-094 replaces them with letters of collaboration, aligning NIH with NSF. Here is exactly what changes, what a compliant letter must now contain, who can no longer write one, and how this fits the broader re-engineering of the NIH application package.
Read articleThe NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read articleThe Cummings Foundation's flagship program will award $35 million to roughly 150 eastern-Massachusetts nonprofits in 2027, up from $30 million — and nearly all of it now flows as unrestricted general operating support. Letters of Inquiry opened July 15 and close September 16, 2026. Here is who qualifies, how the multi-year and 10-year tracks work, and how to write an LOI that survives the first cut.
Read article